With a distinctive presence in the core therapeutic areas viz. critical care and cardiometabolic syndromes our products have proved to be efficient and effective over the short span of time. As experts in the realms of critical care, the company supplies life-saving anti-infective antidotes to various eminent hospitals all across India.
The company has successfully launched a smorgasbord of superior, innovative and affordable products that address the cardiometabolic division and hi-end quality products in the management of DPN: Diabetic Peripheral Neuropathy and for Vitamin D deficiency.
In a bid to further empower their existence in these aforesaid sectors, the company has resolved to introduce innovative, intelligent and improved formulations as quality solutions to these segments. On a sincere note, Converge has aimed to emerge as market-leaders in the divisions of critical care and cardiometabolic, and create a forte in other specialty sectors viz. nephrology, oncology and dermatology.
Indeed, the company’s growth is aided by cost-effective drug development and substantial manufacturing.